Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Protara Therapeutics, Inc.TARA · Entity 6203 | Chief Medical Officer | June 10, 2021 | June 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Protara Therapeutics, Inc.
Report date June 10, 2021 · Filed June 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,344 |
Ending reported balance
After 2021-06-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-06-10 · Purchase · Acquired 4,959 · Balance 9,410 Row 2 · 2021-06-10 · Purchase · Acquired 4,934 · Balance 14,344 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 14, 2021 17:52 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | PurchaseCommon Stock | 4,934 | $10.13 | $49,981.42 |
DisclosureSEC source: 0001209191-21-040311 · doc4.xml · nonDerivative · entry 2 Olivo Martin Sebastian · CIK 0001855055 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,344 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 17:52 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | PurchaseCommon Stock | 4,959 | $10.08 | $49,986.72 |
DisclosureSEC source: 0001209191-21-040311 · doc4.xml · nonDerivative · entry 1 Olivo Martin Sebastian · CIK 0001855055 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,410 Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 20:18 UTC | Protara Therapeutics, Inc. TARA · Entity 6203 | GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $15.30 | $0.00 |
DisclosureSEC source: 0001209191-21-027691 · doc4.xml · derivative · entry 1 Olivo Martin Sebastian · CIK 0001855055 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-04-18 F1 · derivative.exercise_date: One-fourth of the shares shall vest on April 19, 2022 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from April 19, 2022, subject to the Reporting Person's Continuous Service (as defined in the Inducement Plan) with the Issuer through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.